**Core Concept**
Rocuronium is a non-depolarizing neuromuscular blocking agent that belongs to the benzylisoquinolinium class. Its mechanism of action involves competitively blocking nicotinic acetylcholine receptors at the neuromuscular junction. One of its notable characteristics is the potential for causing pain on injection.

**Why the Correct Answer is Right**
Rocuronium causes pain on injection due to its high pH and the presence of a sulfonamide group. When administered intravenously, the drug's high pH can cause irritation to the vascular endothelium, leading to pain and discomfort. Additionally, the sulfonamide group is thought to contribute to the pain sensation by releasing histamine, which can cause vasodilation and further exacerbate the pain.

**Why Each Wrong Option is Incorrect**
**Option A:** Succinyl choline is a depolarizing neuromuscular blocking agent that is known for its potential to cause muscle fasciculations and postoperative myalgia, but it does not typically cause pain on injection.

**Option B:** Vecuronium is another non-depolarizing neuromuscular blocking agent that is less likely to cause pain on injection compared to Rocuronium. Vecuronium's lower pH and lack of a sulfonamide group contribute to its reduced irritant potential.

**Option D:** Cistracurium (presumably a typo for Cisatracurium) is a non-depolarizing neuromuscular blocking agent that is known for its low incidence of histamine release and minimal pain on injection.

**Clinical Pearl / High-Yield Fact**
When administering Rocuronium, it is essential to use a slow injection rate and to dilute the drug in a large volume of saline to minimize the risk of pain on injection. Additionally, the use of a pre-treatment with lidocaine or other local anesthetics may help to reduce the discomfort associated with Rocuronium administration.

**✓ Correct Answer: C. Rocuronium**